PATIENT-REPORTED OUTCOME IMPROVEMENT WITH TOFACITINIB IN THE ULCERATIVE COLITIS OCTAVE CLINICAL PROGRAMME

David P. Hudesman  ¹     Joana Torres  ²     Leonardo Salese  ³     John C. Woolcott     Rajiv Mundayat  ⁴     Chinyu Su     Mahmoud Mosli  ⁵     Jessica Allegretti  ^6    
1 Inflammatory Bowel Disease Center, New York, United States
² Hospital Beatriz Ângelo, Loures, Portugal
³ Pfizer Inc, Collegeville, United States
⁴ Pfizer Inc, New York, United States
⁵ King Abdulaziz University Hospital, Jeddah, Saudi Arabia
⁶ Brigham and Women’s Hospital, Boston, United States

Topic
IBD, Immunology, Paediatrics

Session
Patient outcomes in IBD trials

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)